Obese humans that present with NAFLD have increased circulating and hepatic levels of TNF-α, IL-1β, IL-6 and other acute phase proteins when compared with lean control subjects [7], [18], [52]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.